Marsico Capital Management LLC Biogen Inc. Transaction History

Marsico Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $21.1 Million - $33 Million	-97,272 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $2.38 Million - $3.02 Million	-8,553 Reduced 8.08%	97,272 $29.3 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $31.1 Million - $40.6 Million	105,825 New	105,825 $37.4 Million

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marsico Capital Management LLC with notifications on news.